Experts say early intervention is key to treating and coping with dementia or Alzheimer's. Here's what to keep an eye out for ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

The hypothesis puts forward the idea that stress granules disrupt the cell transport system, which then modifies gene ...

Diabetes is a common, lifelong condition that occurs when the pancreas doesn't produce enough insulin, or when the body is ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...

There isn't a cure for the condition, but doctors may recommend medications to slow down the progression of the disease or ...

Feb. 4, 2025 — Scientists provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer's disease. Their findings, ... Scientists Identify ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...